Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genomic Medicine Center of Excellence, |
RCV003989378 | SCV004808172 | uncertain significance | Cholestasis, intrahepatic, of pregnancy, 3 | 2024-03-29 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004369932 | SCV004901661 | uncertain significance | Inborn genetic diseases | 2022-04-25 | criteria provided, single submitter | clinical testing | The c.1846G>C (p.E616Q) alteration is located in exon 15 (coding exon 14) of the ABCB4 gene. This alteration results from a G to C substitution at nucleotide position 1846, causing the glutamic acid (E) at amino acid position 616 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |